2026 - Hadean Ventures

Complement Therapeutics : First Patient Dosed with CTx001 in the Phase I/II Opti-GAIN Study

by @hadeanventures on March 25, 2026

Complement Therapeutics Announces First Patient Dosed with CTx001 in the Phase I/II Opti-GAIN Study for…
Continue Reading
First patient dosed in Gesynta Pharma’s endometriosis trial of vipoglanstat

by @hadeanventures on March 11, 2026

STOCKHOLM, SWEDEN – March 11, 2026. Gesynta Pharma AB today announced that the first patient…
Continue Reading

What are you looking for?